Comparative Benchmarking
In the context of the broader market, RVPH competes directly with industry leaders such as KYNB and LTRN. With a market capitalization of $29.74M, it holds a significant position in the sector. When comparing efficiency, RVPH's gross margin of N/A stands against KYNB's 105.39% and LTRN's N/A. Such benchmarking helps identify whether Reviva Pharmaceuticals Holdings Inc is trading at a premium or discount relative to its financial performance.
